peptides for sciatica FAQ

Sciatica results from irritation or compression of the sciatic nerve or its nerve root. This causes pain, numbness, or tingling anywhere along the length of the nerve. One of the most common causes of sciatica is a bulging (herniated) disc in the lower back. Discs are small tire-shaped cushions in between the bones of the spine. If the outer rim of a disc tears, usually due to age-related degeneration and routine pressure on the lower back, the damaged disc, the leaking jellylike inner material, or a combination of both exert pressure on the nearby nerve. Other causes of sciatica include spinal stenosis, a narrowing of the spinal canal; spondylolisthesis, a condition in which one of the bones in the spine slips out of alignment; and injury that damages the sciatic nerve. Sciatica can also occur in late pregnancy as the growing baby puts indirect pressure on the sciatic nerve.

Sciatica causes sharp, shooting, or burning pain, tingling, or numbness that radiates down one side of the body from the lower back into the leg and often below the knee. A typical episode lasts from a few days to a week or two. It can be disruptive, and sometimes debilitating. For many people, simple home remedies, staying active, and strengthening and stretching the body can alleviate symptoms. When pain persists, additional medical treatment can help.

Peptides address inflammation and nerve damage. Not structural compression. If your sciatica stems from bone spurs or vertebral narrowing (stenosis), peptides won't widen the spinal canal. They may reduce secondary inflammation around the compressed nerve, which could lower pain intensity, but the mechanical issue remains. Imaging (MRI or CT) confirms the underlying cause. If stenosis is severe, surgical decompression is the only definitive fix.

Yes, but injection site matters significantly. BPC-157 shows systemic effects when injected anywhere subcutaneously, but localized administration near the injury site produces faster results in animal models. For sciatica, inject into the lower back, glute, or posterior thigh within 3–5 inches of where you feel the pain. The peptide's half-life is only 4 hours, so proximity to the nerve root improves local tissue concentration during the active window.

Reassess storage and reconstitution first. If the lyophilised powder was stored above −20°C or the reconstituted solution above 8°C at any point, the peptide is likely inactive. Assuming proper handling, lack of response after 4 weeks suggests one of two scenarios: either the peptide doesn't work for your specific pathology (not all nerve damage responds to growth factor signaling), or the dosage is subtherapeutic. Animal models use 10–15mcg/kg body weight. For a 70kg person, that translates to 700–1050mcg daily, well above the common 250–500mcg range.